10x Science Raises $4.8 Million Seed Round Led By Initialized Capital And Y Combinator

10x Science has raised a $4.8 million seed round led by Initialized Capital, with participation from Y Combinator, Civilization Ventures, and Founder Factor. The transaction addresses a vital aspect of drug discovery by providing AI tools aimed at identifying valuable drug candidates amidst a surge of AI-generated molecules requiring validation.

Summary of transaction details:

• Deal Type: Seed
• Transaction Amount: $4,800,000
• Company: 10x Science
• Founders: David Roberts & Andrew Reiter
• Headquarters: San Francisco, California
• Notable Investors: Initialized Capital, Y Combinator, Civilization Ventures, Founder Factor

Founded in December 2025, 10x Science operates at the intersection of biochemistry and technology, aiming to alleviate challenges in drug discovery through a platform that merges deterministic models with AI to analyze complex mass spectrometry data. This innovative approach helps in expediting protein structure analysis for biologic drug development.